Eric Francis Yves Thepaut - May 2, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP & Pres, Eur, Mid-East, Afr
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
May 2, 2023
Transactions value $
-$3,981,975
Form type
4
Date filed
5/3/2023, 04:56 PM
Previous filing
Feb 22, 2023
Next filing
Jan 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $396K +30.7K +47.23% $12.89 95.7K May 2, 2023 Direct
transaction BSX Common Stock Sale -$4.38M -83.4K -87.18% $52.49 12.3K May 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Stock Option (Right to Buy) Options Exercise $0 -30.7K -100% $0.00* 0 May 2, 2023 Common Stock 30.7K $12.89 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.46 to $52.52, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on December 1, 2015, the first anniversary of the date of grant.